American Portfolios Advisors Veracyte, Inc. Transaction History
American Portfolios Advisors
- $2.36 Trillion
- Q3 2022
A detailed history of American Portfolios Advisors transactions in Veracyte, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 8,818 shares of VCYT stock, worth $342,932. This represents 0.01% of its overall portfolio holdings.
Number of Shares
8,818Holding current value
$342,932% of portfolio
0.01%Shares
4 transactions
Others Institutions Holding VCYT
# of Institutions
272Shares Held
78.6MCall Options Held
42.3KPut Options Held
18.2K-
Black Rock Inc. New York, NY7.79MShares$303 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.5MShares$292 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA6.88MShares$267 Million0.03% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.02MShares$195 Million0.27% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.92MShares$191 Million1.59% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.78B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...